Honey Luxemburg
Chief Financial Officer, MediWound
Replay available
MediWound Ltd. (NASDAQ: MDWD) Q3 2025 earnings conference call, held 2025-11-20. Replay captured from the company's public earnings webcast.

Chief Financial Officer, MediWound
Chief Executive Officer, MediWound
Analyst, Maxim Group
Analyst, Oppenheimer
EVP of Strategy and Corporate Development, MediWound
Analyst, TD Cowen
Good morning, everyone, and welcome to the MediWOON's third quarter 2025 earnings call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star and then one using a touch-tone telephone. To withdraw your questions, you may press star and two. Please also note today's event is being recorded. And at this time, I'd like to turn the floor over to Dan Ferry of LifeSci Advisors. Please go ahead. Thank you, Operator, and welcome, everyone. We're here today, pre-market open, medical initiative press release, announcing financial results for the third quarter ended September 30, 2025. You may access this press release on the company's website under the Investors tab. It would ask you to review the full text of our forward-looking statements within this morning's press release. Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session, relating to anyone's expected future performance, future business prospects, or future events or plans are forward-looking statements, as defined under the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that could cause actual results to differ materially from expectations and are described more fully in our filings with the SEC. In addition, all forward-looking statements represent our views only as of today, and MediWound assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events, or otherwise. This conference calls the property of MediWound, and any ...